Display options
Cite
Ingrasci G, El-Kashlan N, Alexis A, et al. Chronic itch in African Americans: an unmet need. Arch Dermatol Res. 2021;doi: 10.1007/s00403-021-02255-6.
Ingrasci, G., El-Kashlan, N., Alexis, A., & Yosipovitch, G. (2021). Chronic itch in African Americans: an unmet need. Archives of dermatological research, . https://doi.org/10.1007/s00403-021-02255-6
Ingrasci, Giuseppe, et al. "Chronic itch in African Americans: an unmet need." Archives of dermatological research vol. (2021). doi: https://doi.org/10.1007/s00403-021-02255-6
Ingrasci G, El-Kashlan N, Alexis A, Yosipovitch G. Chronic itch in African Americans: an unmet need. Arch Dermatol Res. 2021 Jun 15; doi: 10.1007/s00403-021-02255-6. Epub 2021 Jun 15. PMID: 34129098.
Copy Download .nbib Format: NLM
Share it on

Arch Dermatol Res. 2021 Jun 15; doi: 10.1007/s00403-021-02255-6. Epub 2021 Jun 15.

Chronic itch in African Americans: an unmet need.

Archives of dermatological research

Giuseppe Ingrasci, Nour El-Kashlan, Andrew Alexis, Gil Yosipovitch

Affiliations

  1. Dr. Phillip Frost Department of Dermatology and Miami Itch Center, University of Miami, Miami, FL, USA.
  2. The Kimberly and Eric J. Waldman Department of Dermatology at the Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  3. Dr. Phillip Frost Department of Dermatology and Miami Itch Center, University of Miami, Miami, FL, USA. [email protected].

PMID: 34129098 DOI: 10.1007/s00403-021-02255-6

Abstract

Chronic pruritus carries a significant burden of disease and is associated with a negative impact on quality of life. African Americans are disproportionately burdened by chronic pruritic disorders, including but not limited to atopic dermatitis, prurigo nodularis, inflammatory scalp dermatoses, pathologic scarring, and HIV-related dermatoses. Racial differences in skin structure and function may contribute to the pathogenesis of itch in African Americans. Itch perception and response to treatment in African Americans remain understudied and not well understood. As such, there is a large unmet need with regard to the knowledge and management of pruritus in African Americans. This review highlights notable differences in the epidemiology, pathophysiology, genetic predisposition, clinical presentation, and response to treatment for select pruritic skin conditions. By addressing itch as an unmet need in African Americans, we hope to improve patient outcomes and lessen disparities in dermatologic care.

Keywords: Acne keloidalis nuchae; African Americans; Atopic dermatitis; Central centrifugal cicatricial alopecia; Chronic itch; Hypertrophic scar formation; Keloid; Post-burn pruritus; Prurigo nodularis; Pruritic papular eruption of HIV; Pruritus; Seborrheic dermatitis

References

  1. Yosipovitch G, Bernhard JD (2013) Chronic pruritus. N Engl J Med 368(17):1625–1634 - PubMed
  2. Alexis AF, Barbosa VH (2013) Skin of color: a practical guide to dermatologic diagnosis and treatment. Springer, New York - PubMed
  3. Whang KA, Khanna R, Thomas J, Aguh C, Kwatra SG (2019) Racial and gender differences in the presentation of pruritus. Medicines (Basel, Switzerland) 6(4):98 - PubMed
  4. Caretti KL, Mehregan DR, Mehregan DA (2015) A survey of self-reported skin disease in the elderly African-American population. Int J Dermatol 54(9):1034–1038 - PubMed
  5. Mollanazar NK, Sethi M, Rodriguez RV, Nattkemper LA, Ramsey FV, Zhao H, Yosipovitch G (2016) Retrospective analysis of data from an itch center: integrating validated tools in the electronic health record. J Am Acad Dermatol 75(4):842–844 - PubMed
  6. Shaw FMMD, Luk KMHBS, Chen K-HP, Wrenn GMDM, Chen SCMDMS (2017) Racial disparities in the impact of chronic pruritus: A cross-sectional study on quality of life and resource utilization in United States Veterans. J Am Acad Dermatol 77(1):63–69 - PubMed
  7. Ono K, Viet CT, Ye Y, Dang D, Hitomi S, Toyono T, Inenaga K, Dolan JC, Schmidt BL (2017) Cutaneous pigmentation modulates skin sensitivity via tyrosinase-dependent dopaminergic signalling. Sci Rep 7(1):9181–9113 - PubMed
  8. Wang H, Papoiu ADP, Coghill RC, Patel T, Wang N, Yosipovitch G (2010) Ethnic differences in pain, itch and thermal detection in response to topical capsaicin: African Americans display a notably limited hyperalgesia and neurogenic inflammation. Br J Dermatol 162(5):1023–1029 - PubMed
  9. Heller D, Doyle JR, Raman VS, Beinborn M, Kumar K, Kopin AS (2016) Novel probes establish Mas-related G protein-coupled receptor X1 variants as receptors with loss or gain of function. J Pharmacol Exp Ther 356(2):276–283 - PubMed
  10. Zhang L, McNeil BD (2019) Beta-defensins are proinflammatory pruritogens that activate Mrgprs. J Allergy Clin Immunol 143(5):1960-1962.e1965 - PubMed
  11. Jurevic RJ, Chrisman P, Mancl L, Livingston R, Dale BA (2002) Single-nucleotide polymorphisms and haplotype analysis in β-defensin genes in different ethnic populations. Genet Test 6(4):261–269 - PubMed
  12. McGregor SP, Farhangian ME, Huang KE, Feldman SR (2017) Treatment of atopic dermatitis in the united states: analysis of data from the national ambulatory medical care survey. J Drugs Dermatol 16(3):250–255 - PubMed
  13. Davis SA, Narahari S, Feldman SR, Huang W, Pichardo-Geisinger RO, McMichael AJ (2012) Top dermatologic conditions in patients of color: an analysis of nationally representative data. J Drugs Dermatol 11(4):466–473 - PubMed
  14. Shaw TE, Currie GP, Koudelka CW, Simpson EL (2011) Eczema prevalence in the United States: data from the 2003 National Survey of Children’s Health. J Investig Dermatol 131(1):67–73 - PubMed
  15. Paternoster L, Standl M, Waage J, Baurecht H, Hotze M, Strachan DP, Curtin JA, Bonnelykke K, Tian C, Takahashi A et al (2015) Multi-ancestry genome-wide association study of 21,000 cases and 95,000 controls identifies new risk loci for atopic dermatitis. Nat Genet 47(12):1449–1456 - PubMed
  16. Kaufman BP, Guttman-Yassky E, Alexis AF (2018) Atopic dermatitis in diverse racial and ethnic groups-variations in epidemiology, genetics, clinical presentation and treatment. Exp Dermatol 27(4):340–357 - PubMed
  17. Vachiramon V, Tey HL, Thompson AE, Yosipovitch G (2012) Atopic dermatitis in African American children: addressing unmet needs of a common disease: atopic dermatitis in African American children. Pediatr Dermatol 29(4):395–402 - PubMed
  18. Wesley NO, Maibach HI (2003) Racial (ethnic) differences in skin properties: the objective data. Am J Clin Dermatol 4(12):843–860 - PubMed
  19. Shea P, Presnell SR, Foster D, Topouzis S, Johnston J, Bort S, Dong DL, Maurer M, Mudri S, Kuijper JL et al (2004) Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice. Nat Immunol 5(7):752–760 - PubMed
  20. Feld M, Garcia R, Buddenkotte J, Katayama S, Lewis K, Muirhead G, Hevezi P, Plesser K, Schrumpf H, Krjutskov K et al (2016) The pruritus- and TH2-associated cytokine IL-31 promotes growth of sensory nerves. J Allergy Clin Immunol 138(2):500-508.e524 - PubMed
  21. Mollanazar NK, Smith PK, Yosipovitch G (2015) Mediators of chronic pruritus in atopic dermatitis: getting the itch out? Clin Rev Allergy Immunol 51(3):263–292 - PubMed
  22. Sanyal RD, Pavel AB, Glickman J, Chan TC, Zheng X, Zhang N, Cueto I, Peng X, Estrada Y, Fuentes-Duculan J et al (2019) Atopic dermatitis in African American patients is T H 2/T H 22-skewed with T H 1/T H 17 attenuation. Ann Allergy Asthma Immunol 122(1):99 - PubMed
  23. Andoh T, Akasaka C, Shimizu K, Lee J-B, Yoshihisa Y, Shimizu T (2019) Involvement of α-melanocyte-stimulating hormone-thromboxane a 2 system on itching in atopic dermatitis. Am J Pathol 189(9):1775 - PubMed
  24. Babiarz-Magee L, Chen N, Seiberg M, Lin CB (2004) The expression and activation of protease-activated receptor-2 correlate with skin color. Pigment Cell Res 17(3):241–251 - PubMed
  25. Järvikallio A, Harvima IT, Naukkarinen A (2003) Mast cells, nerves and neuropeptides in atopic dermatitis and nummular eczema. Arch Dermatol Res 295(1):2–7 - PubMed
  26. Andoh T, Akasaka C, Shimizu K, Lee J-B, Yoshihisa Y, Shimizu T (2019) Involvement of α-melanocyte–stimulating hormone-thromboxane A2 system on itching in atopic dermatitis. Am J Pathol 189(9):1775–1785 - PubMed
  27. Serhan N, Basso L, Sibilano R, Petitfils C, Meixiong J, Bonnart C, Reber LL, Marichal T, Starkl P, Cenac N et al (2019) House dust mites activate nociceptor-mast cell clusters to drive type 2 skin inflammation. Nat Immunol 20(11):1435–1443 - PubMed
  28. Ayudhya CCN, Roy S, Alkanfari I, Ganguly A, Ali H (2019) Identification of gain and loss of function missense variants in MRGPRX2’s transmembrane and intracellular domains for mast cell activation by substance P. Int J Mol Sci 20(21):5247 - PubMed
  29. Gupta K, Subramanian H, Ali H (2016) Modulation of host defense peptide-mediated human mast cell activation by LPS. Innate Immunity (London, England) 22(1):21–30 - PubMed
  30. An J, Lee JH, Won HK, Kang Y, Song WJ, Kwon HS, Cho YS, Moon HB, Kim TB (2020) Clinical significance of serum MRGPRX2 as a new biomarker in allergic asthma. Allergy (Copenhagen) 75(4):959–962 - PubMed
  31. Fujisawa DMD, Kashiwakura J-iP, Kita HMDP, Kikukawa YM, Fujitani YP, Sasaki-Sakamoto TB, Kuroda KP, Nunomura SP, Hayama KMDP, Terui TMDP et al (2014) Expression of Mas-related gene X2 on mast cells is upregulated in the skin of patients with severe chronic urticaria. J Allergy Clin Immunol 134(3):622-633.e629 - PubMed
  32. Summey BT, Bowen SE, Allen HB (2008) Lichen planus-like atopic dermatitis: expanding the differential diagnosis of spongiotic dermatitis. J Cutan Pathol 35(3):311–314 - PubMed
  33. Berardesca E, Maibach H (2003) Ethnic skin: overview of structure and function. J Am Acad Dermatol 48(6):S139–S142 - PubMed
  34. Ben-Gashir MA, Seed PT, Hay RJ (2002) Reliance on erythema scores may mask severe atopic dermatitis in black children compared with their white counterparts. Br J Dermatol (1951) 147(5):920–925 - PubMed
  35. Callender VD, Alexis AF, Stein Gold LF, Lebwohl MG, Paller AS, Desai SR, Tan H, Ports WC, Zielinski MA, Tallman AM (2019) Efficacy and safety of crisaborole ointment, 2%, for the treatment of mild-to-moderate atopic dermatitis across racial and ethnic groups. Am J Clin Dermatol 20(5):711–723 - PubMed
  36. Simpson EL, Bieber T, Guttman-Yassky E, Beck LA, Blauvelt A, Cork MJ, Silverberg JI, Deleuran M, Kataoka Y, Lacour J-P et al (2016) Two phase 3 trials of dupilumab versus placebo in atopic dermatitis. N Engl J Med 375(24):2335–2348 - PubMed
  37. Boozalis E, Tang O, Patel S, Semenov YR, Kwatra S (2018) 1273 Ethnic differences and comorbidities of 909 Prurigo nodularis patients: a cohort study at Johns Hopkins Hospital. J Investig Dermatol 138(5):S216–S216 - PubMed
  38. Whang KA, Kang S, Kwatra SG (2019) Inpatient burden of prurigo nodularis in the United States. Medicines (Basel, Switzerland) 6(3):88 - PubMed
  39. Bolognia J, Schaffer JV, Duncan KO, Ko CJ (2014) Dermatology essentials. Saunders/Elsevier, Oxford - PubMed
  40. Zeidler C, Yosipovitch G, Ständer S (2018) Prurigo nodularis and its management. Dermatol Clin 36(3):189–197 - PubMed
  41. Sonkoly E, Muller A, Lauerma AI, Pivarcsi A, Soto H, Kemeny L, Alenius H, Dieu-Nosjean M-C, Meller S, Rieker J et al (2006) IL-31: A new link between T cells and pruritus in atopic skin inflammation. J Allergy Clin Immunol 117(2):411–417 - PubMed
  42. Hashimoto T, Nattkemper LA, Kim HS, Kursewicz CD, Fowler E, Shah SM, Nanda S, Fayne RA, Romanelli P, Yosipovitch G (2021) Dermal periostin: a new player in itch of prurigo nodularis. Acta Derm Venereol 101(1):adv00375 - PubMed
  43. Zhai LL, Savage KT, Qiu CC, Jin A, Valdes-Rodriguez R, Mollanazar NK (2019) Chronic pruritus responding to dupilumab—a case series. Medicines (Basel, Switzerland) 6(3):72 - PubMed
  44. Ständer S, Yosipovitch G, Legat FJ, Lacour J-P, Paul C, Narbutt J, Bieber T, Misery L, Wollenberg A, Reich A et al (2020) Trial of nemolizumab in moderate-to-severe prurigo nodularis. N Engl J Med 382(8):706–716 - PubMed
  45. Therapeutics T (2015) Study of Nalbuphine HCl ER Tablets in Patients With Prurigo Nodularis. https://ClinicalTrials.gov/show/NCT02174419 . Accessed 10 Feb 2021  - PubMed
  46. Olsen EAMD, Callender VMD, McMichael AMD, Sperling LMD, Anstrom KJP, Shapiro JMD, Roberts JMD, Durden FMD, Whiting DMD, Bergfeld WMD (2010) Central hair loss in African American women: incidence and potential risk factors. J Am Acad Dermatol 64(2):245–252 - PubMed
  47. Khumalo NP, Jessop S, Gumedze F, Ehrlich R (2007) Hairdressing and the prevalence of scalp disease in African adults. Br J Dermatol 157(5):981–988 - PubMed
  48. Salam A, Aryiku S, Dadzie OE (2013) Hair and scalp disorders in women of African descent: an overview. Br J Dermatol 169(s3):19–32 - PubMed
  49. Ogunbiyi A (2016) Acne keloidalis nuchae: prevalence, impact, and management challenges. Clin Cosmet Investig Dermatol 9:483–489 - PubMed
  50. Taylor SC, Barbosa V, Burgess C, Heath C, McMichael AJ, Ogunleye T, Callender V (2017) Hair and scalp disorders in adult and pediatric patients with skin of color. Cutis (New York, NY) 100(1):31–35 - PubMed
  51. Shah SK, Alexis AF (2010) Central centrifugal cicatricial alopecia: retrospective chart review. J Cutan Med Surg 14(5):212–222 - PubMed
  52. Callender VD, Kazemi A, Young CM, Chappell JA, Sperling LC (2020) Safety and efficacy of clobetasol propionate 0.05% emollient foam for the treatment of central centrifugal cicatricial alopecia. J Drugs Dermatol 19(7):719–724 - PubMed
  53. Amadesi S (2004) Protease-activated receptor 2 sensitizes the capsaicin receptor transient receptor potential vanilloid receptor 1 to induce hyperalgesia. J Neurosci 24(18):4300–4312 - PubMed
  54. Bin Saif GA, McMichael A, Kwatra SG, Chan YH, Yosipovitch G (2013) Central centrifugal cicatricial alopecia severity is associated with cowhage-induced itch. Br J Dermatol 168(2):253–256 - PubMed
  55. Dlova NCMF, Jordaan FHMM, Sarig OP, Sprecher EMDP (2014) Autosomal dominant inheritance of central centrifugal cicatricial alopecia in black South Africans. J Am Acad Dermatol 70(4):679-682.e671 - PubMed
  56. Cau L, Méchin M-C, Simon M (2018) Peptidylarginine deiminases and deiminated proteins at the epidermal barrier. Exp Dermatol 27(8):852–858 - PubMed
  57. Malki L, Sarig O, Romano M-T, Méchin M-C, Peled A, Pavlovsky M, Warshauer E, Samuelov L, Uwakwe L, Briskin V et al (2019) Variant PADI3 in central centrifugal cicatricial alopecia. N Engl J Med 380(9):833–841 - PubMed
  58. Bin Saif GA, Ericson ME, Yosipovitch G (2011) The itchy scalp—scratching for an explanation. Exp Dermatol 20(12):959–968 - PubMed
  59. Shevchenko ABS, Valdes-Rodriguez RMD, Yosipovitch GMD (2017) Causes, pathophysiology, and treatment of pruritus in the mature patient. Clin Dermatol 36(2):140–151 - PubMed
  60. Elgash M, Dlova N, Ogunleye T, Taylor SC (2019) Seborrheic dermatitis in skin of color: clinical considerations. J Drugs Dermatol 18(1):24–27 - PubMed
  61. (2014) Seborrheic dermatitis of the scalp in populations practicing less frequent hair washing: Ketoconazole 2% foam versus ketoconazole 2% shampoo. Three-year data. J Am Acad Dermatol 70(5):AB54–AB54 - PubMed
  62. Chika I, Tatsuya T, Hiroe K, Noboru N, Kiyofumi Y (2009) Tetracyclines modulate protease-activated receptor 2-mediated proinflammatory reactions in epidermal keratinocytes. Antimicrob Agents Chemother 53(5):1760–1765 - PubMed
  63. Kelly AP (1988) Keloids. Dermatol Clin 6(3):413–424 - PubMed
  64. Robles DT, Berg D (2007) Abnormal wound healing: keloids. Clin Dermatol 25(1):26–32 - PubMed
  65. Aköz T, Gideroğlu K, Akan M (2002) Combination of different techniques for the treatment of earlobe keloids. Aesthetic Plast Surg 26(3):184–188 - PubMed
  66. Bernhard JD (1994) Itch: mechanisms and management of pruritus. McGraw-Hill, New York - PubMed
  67. Lee S-S, Yosipovitch G, Chan Y-H, Goh C-L (2004) Pruritus, pain, and small nerve fiber function in keloids: a controlled study. J Am Acad Dermatol 51(6):1002–1006 - PubMed
  68. Kassi K, Kouame K, Kouassi A, Allou A, Kouassi I, Kourouma S, Ecra E, Sangare A (2020) Quality of life in black African patients with keloid scars. Dermatol Rep 12(2):8312. https://doi.org/10.4081/dr.2020.8312 - PubMed
  69. Thompson CM, Hocking AM, Honari S, Muffley LA, Ga M, Gibran NS (2013) Genetic risk factors for hypertrophic scar development. J Burn Care Res 34(5):477–482 - PubMed
  70. Carrougher GJ, Martinez EM, McMullen KS, Fauerbach JA, Holavanahalli RK, Herndon DN, Wiechman SA, Engrav LH, Gibran NS (2013) Pruritus in adult burn survivors: postburn prevalence and risk factors associated with increased intensity. J Burn Care Res 34(1):94–101 - PubMed
  71. Chung BY, Kim HB, Jung MJ, Kang SY, Kwak I-S, Park CW, Kim HO (2020) Post-burn pruritus. Int J Mol Sci 21(11):3880 - PubMed
  72. Tey HL, Maddison B, Wang H, Ishiju Y, McMichael A, Marks M, Willford P, Maruzivab D, Ferdinando D, Dick J et al (2012) Cutaneous innervation and itch in keloids. Acta Derm Venereol 92(5):529–531 - PubMed
  73. Sueki H, Whitaker-Menezes D, Kligman AM (2001) Structural diversity of mast cell granules in black and white skin. Br J Dermatol (1951) 144(1):85–93 - PubMed
  74. Brain SD (2000) New feelings about the role of sensory nerves in inflammation. Nat Med 6(2):134–135 - PubMed
  75. Jianni W, Del Ester D, Michael E, Alyssa G, Inna C, Ning Z, Yeriel DE, Ana BP, James GK, Emma G-Y (2020) RNA sequencing keloid transcriptome associates keloids With Th2, Th1, Th17/Th22, and JAK3-skewing. Front Immunol. https://doi.org/10.3389/fimmu.2020.597741 - PubMed
  76. Montagna W, Carlisle K (1991) The architecture of black and white facial skin. J Am Acad Dermatol 24(6):929–937 - PubMed
  77. Maeda D, Kubo T, Kiya K, Kawai K, Matsuzaki S, Kobayashi D, Fujiwara T, Katayama T, Hosokawa K (2019) Periostin is induced by IL-4/IL-13 in dermal fibroblasts and promotes RhoA/ROCK pathway-mediated TGF-beta 1 secretion in abnormal scar formation. J Plast Surg Hand Surg 53(5):288–294 - PubMed
  78. Lee YS, Vijayasingam S (1995) Mast cells and myofibroblasts in keloid: a light microscopic, immunohistochemical and ultrastructural study. Ann Acad Med Singap 24(6):902–905 - PubMed
  79. Shikuma CM, McArthur JC, Ebenezer GJ, Ananworanich J, Teeratakulpisarn N, Jadwattanakul T, Valcour VG, Bennett K, Phanuphak N (2013) Ethnic differences in epidermal nerve fiber density. Muscle Nerve 48(3):462–464 - PubMed
  80. Clark JA, Turner ML, Howard L, Stanescu H, Kleta R, Kopp JB (2009) Description of familial keloids in five pedigrees: evidence for autosomal dominant inheritance and phenotypic heterogeneity. BMC Dermatol 9(1):8–8 - PubMed
  81. Marneros AG, Norris JEC, Watanabe S, Reichenberger E, Olsen BR (2004) Genome scans provide evidence for keloid susceptibility loci on chromosomes 2q23 and 7p11. J Investig Dermatol 122(5):1126–1132 - PubMed
  82. Oh J, Fernando A, Muffley L, Honari S, Gibran NS (2020) Correlation between the warrior/worrier gene on post burn pruritus and scarring: a prospective cohort study. Ann Surg. https://doi.org/10.1097/SLA.0000000000004235 - PubMed
  83. Diaz A, Tan K, He H, Xu H, Cueto I, Pavel AB, Krueger JG, Guttman-Yassky E (2020) Keloid lesions show increased IL-4/IL-13 signaling and respond to Th2-targeting dupilumab therapy. J Eur Acad Dermatol Venereol 34(4):e161–e164 - PubMed
  84. Battle NC, Choudhry S, Tsai H-J, Eng C, Kumar G, Beckman KB, Naqvi M, Meade K, Watson HG, LeNoir M et al (2007) Ethnicity-specific gene-gene interaction between IL-13 and IL-4R{alpha} among African Americans with Asthma. Am J Respir Crit Care Med 175(9):881 - PubMed
  85. Lu Y-Y, Lu C-C, Yu W-W, Zhang L, Wang Q-R, Zhang C-L, Wu C-H (2018) Keloid risk in patients with atopic dermatitis: a nationwide retrospective cohort study in Taiwan. BMJ Open 8(7):e022865–e022865 - PubMed
  86. Liautaud B, Pape JW, DeHovitz JA, Thomas F, LaRoche AC, Verdier RI, Deschamps M-M, Johnson WD (1989) Pruritic skin lesions: a common initial presentation of acquired immunodeficiency syndrome. Arch Dermatol 125(5):629–632 - PubMed
  87. Lowe S, Ferrand RA, Morris-Jones R, Salisbury J, Mangeya N, Dimairo M, Miller RF, Corbett EL (2010) Skin disease among human immunodeficiency virus-infected adolescents in Zimbabwe: a strong indicator of underlying HIV infection. Pediatr Infect Dis J 29(4):346–351 - PubMed
  88. Akinboro AO, Onayemi O, Mejiuni AD (2014) Frequency, pattern, and extent of skin diseases in relation to CD4+ cell count among adults with human immunodeficiency virus infection or acquired immunodeficiency syndrome in Osogbo, southwestern Nigeria. Int J Dermatol 53(4):416–424 - PubMed
  89. Centers for Disease Control and Prevention (2020) HIV Surveillance Report, 2018 (Updated), vol 31. In: HIV Surveillance Report. Centers for Disease Control and Prevention. Accessed 10 Feb 2021 - PubMed
  90. Ekpe O (2019) Pruritic papular eruption of HIV: a review article. Nasza Dermatol Online 10(2):191–196 - PubMed
  91. Hevia O, Jimenez-Acosta F, Ceballos PI, Gould EW, Penneys NS (1991) Pruritic papular eruption of the acquired immunodeficiency syndrome: a clinicopathologic study. J Am Acad Dermatol 24(2):231–235 - PubMed
  92. Resneck JS, Van Beek M, Furmanski L, Oyugi J, LeBoit PE, Katabira E, Kambugu F, Maurer T, Berger T, Pletcher MJ et al (2004) Etiology of pruritic papular eruption with HIV infection in Uganda. JAMA J Am Med Assoc 292(21):2614–2621 - PubMed
  93. Boonchai W, Md RL, Manonukul J, Kulthanan K (1999) Pruritic papular eruption in HIV seropositive patients: a cutaneous marker for immunosuppression. Int J Dermatol 38(5):348–350 - PubMed
  94. Chua SL, Amerson EH, Leslie KS, McCalmont TH, Leboit PE, Martin JN, Bangsberg D, Maurer TA (2014) Factors associated with pruritic papular eruption of human immunodeficiency virus infection in the antiretroviral therapy era. Br J Dermatol (1951) 170(4):832–839 - PubMed
  95. Buchness MR, Lim HW, Hatcher VA, Sanchez M, Soter NA (1988) Eosinophilic pustular folliculitis in the acquired immunodeficiency syndrome. Treatment with ultraviolet B phototherapy. N Engl J Med 318(18):1183 - PubMed
  96. Pardo RJ, Bogaert MA, Penneys NS, Byrne GE, Ruiz P (1992) UVB phototherapy of the pruritic papular eruption of the acquired immunodeficiency syndrome. J Am Acad Dermatol 26(3):423–428 - PubMed
  97. Cline BK, Vreman HJ, Faber K, Lou H, Donaldson KM, Amuabunosi E, Ofovwe G, Bhutani VK, Olusanya BO, Slusher TM (2013) Phototherapy device effectiveness in Nigeria: irradiance assessment and potential for improvement. J Trop Pediatr 59(4):321–325 - PubMed
  98. Owa JA, Adebami OJ, Fadero FF, Slusher TM (2011) Irradiance readings of phototherapy equipment: Nigeria. Indian J Pediatr 78(8):996–998 - PubMed
  99. Ware OR, Guiyab J, Okoye GA (2020) Phototherapy in skin of color. Dermatol Clin 38(1):63–69 - PubMed
  100. Bilu D, Mamelak AJ, Nguyen RHN, Queiroz PC, Kowalski J, Morison WL, Martins CR (2004) Clinical and epidemiologic characterization of photosensitivity in HIV-positive individuals. Photodermatol Photoimmunol Photomed 20(4):175–183 - PubMed

Publication Types